Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer
about
Longitudinal Assessment of Lung Cancer Progression in Mice Using the Sodium Iodide Symporter Reporter Gene and SPECT/CT ImagingData to establish the optimal standard regimen and predicting the response to docetaxel therapyCombination of metformin and curcumin targets breast cancer in mice by angiogenesis inhibition, immune system modulation and induction of p53 independent apoptosis.1,1-Bis(3'-indolyl)-1-(p-bromophenyl)methane and related compounds repress survivin and decrease gamma-radiation-induced survivin in colon and pancreatic cancer cellsTheranostic tumor homing nanocarriers for the treatment of lung cancerFormulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers.Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer.3,3'-Diindolylmethane (DIM) inhibits the growth and invasion of drug-resistant human cancer cells expressing EGFR mutantsAttenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic.Enhanced anticancer activity of gemcitabine in combination with noscapine via antiangiogenic and apoptotic pathway against non-small cell lung cancer.Inhalation delivery of a novel diindolylmethane derivative for the treatment of lung cancerChemoprevention of skin cancer with 1,1-Bis (3'-indolyl)-1-(aromatic) methane analog through induction of the orphan nuclear receptor, NR4A2 (Nurr1)Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer.STAT6 siRNA matrix-loaded gelatin nanocarriers: formulation, characterization, and ex vivo proof of concept using adenocarcinoma cellsPharmacokinetic evaluation and in vitro-in vivo correlation (IVIVC) of novel methylene-substituted 3,3' diindolylmethane (DIM).Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR.Enhanced Anticancer Activity of PF-04691502, a Dual PI3K/mTOR Inhibitor, in Combination With VEGF siRNA Against Non-small-cell Lung CancerDevelopment of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer.Tumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer.1,1-Bis (3'-indolyl)-1-(p-substitutedphenyl)methane compounds inhibit lung cancer cell and tumor growth in a metastasis model.Targeting NR4A1 (TR3) in cancer cells and tumorsRegressions of Breast Carcinoma Syngraft Following Treatment with Piperine in Combination with Thymoquinone.Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer.Evaluation of self-emulsified DIM-14 in dogs for oral bioavailability and in Nu/nu mice bearing stem cell lung tumor models for anticancer activity.Evaluation of Spray BIO-Max DIM-P in Dogs for Oral Bioavailability and in Nu/nu Mice Bearing Orthotopic/Metastatic Lung Tumor Models for Anticancer Activity.EphA2 targeting pegylated nanocarrier drug delivery system for treatment of lung cancer.Myriocin induces apoptotic lung cancer cell death via activation of DR4 pathway.Relative impact of 3- and 5-hydroxyl groups of cytosporone B on cancer cell viability.Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel.Novel hydrophilic docetaxel (CQMU-0519) analogue inhibits proliferation and induces apoptosis in human A549 lung, SKVO3 ovarian and MCF7 breast carcinoma cell lines.Inhibitory effect of the low-toxic exogenous aryl hydrocarbon receptor modulator 3'3-diindolylmethane on gastric cancer in mice.3,3'-Diindolylmethane enhances apoptosis in docetaxel-treated breast cancer cells by generation of reactive oxygen speciesCombined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway
P2860
Q28468469-06D0BDE7-A738-43F7-AA9E-E124A43F398AQ31027264-6EE7CC56-449B-463F-AF55-7BBB6DDF7329Q33605925-542E77A0-C2BB-4146-B81A-6A31E9DAA002Q33748743-E08E04AA-BCF8-4ECD-B2E1-887309531C60Q33769951-DFD72D0F-C27B-4718-BD7E-3A1D43E88B73Q33846935-90F890EA-34C9-4212-B73D-9939EE3213B2Q33851448-F3787709-D175-429D-8670-599778EBB88CQ33937876-D3D6A9B4-1E1F-4B52-A910-831623EA6C60Q33997903-D44211EF-48D7-4871-9E08-1502A7207573Q34079286-B7E49D6D-16BD-4CCA-B12B-76BD6798CBCCQ34300257-B6610AC5-A767-47B9-94E3-99C4FB1A3E91Q34946349-D8721BCA-F95D-4B36-B454-989F8A323B5AQ34982543-A7E862B7-3453-4BBA-9113-38E7FF588ED0Q35031755-5C5BCE01-6927-4AD2-9BD2-882442094AF4Q36030100-6801330F-0058-470B-8316-844ECE551BA6Q36054864-0C3834EE-3471-4BD0-87EB-FD16F3BE5692Q36192506-449F71B9-DF3F-4390-8602-9EE0DCA35FF4Q36302124-FA26018B-A174-449E-B9D6-87A5664B388CQ37013337-3C9FB3AA-B491-4E32-B8E9-6614F28023BCQ37338514-E673B788-1859-42D6-9D6C-4B9D856A6C85Q37825901-A754FE2F-2F84-43CD-9EB5-84395B154F11Q38698255-529AF13B-39F5-46DD-9B1A-BD1F3B68B89DQ38778869-79ECFEDD-8DEF-4307-A43D-6804F0A9E8C6Q38863616-9D4AFEB5-F2B3-40AB-9DA1-6D1310A72443Q38921461-58736766-3088-40AC-AFFC-0A6879885DDBQ38990966-68F0AFC9-C8E3-49AB-A108-B593EB69360AQ39036953-6CC7D7CA-DD4D-41A2-99DF-D9F5640129B8Q39085651-3E0A2B2D-4DD3-4E57-9D98-00A8CF6FFBC7Q39202347-9FFEE3A7-CCDC-4FE6-95D5-F5212DDEA450Q39336275-60300276-0FD5-49CD-821E-C675A750E8A8Q49712735-DA143102-1E46-41B1-927B-7C6F83645410Q57279728-50FCFB16-CE5A-43EA-A4C2-9444A37BED0DQ58735770-4BDF0EED-83B2-4FA2-ACF9-29340823E3A6
P2860
Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Enhancement of docetaxel antic ...... man non-small cell lung cancer
@ast
Enhancement of docetaxel antic ...... man non-small cell lung cancer
@en
type
label
Enhancement of docetaxel antic ...... man non-small cell lung cancer
@ast
Enhancement of docetaxel antic ...... man non-small cell lung cancer
@en
prefLabel
Enhancement of docetaxel antic ...... man non-small cell lung cancer
@ast
Enhancement of docetaxel antic ...... man non-small cell lung cancer
@en
P2093
P2860
P1476
Enhancement of docetaxel antic ...... man non-small cell lung cancer
@en
P2093
Mahavir B Chougule
Mandip Singh
Nkechi Ichite
Stephen Safe
Suniket V Fulzele
Tanise Jackson
P2860
P304
P356
10.1158/1078-0432.CCR-08-1558
P407
P577
2009-01-01T00:00:00Z